Against Monopoly
defending the right to innovate
Monopoly corrupts. Absolute monopoly corrupts absolutely.
Copyright Notice: We don't think much of copyright, so you can do what you want with the content on this blog. Of course we are hungry for publicity, so we would be pleased if you avoided plagiarism and gave us credit for what we have written. We encourage you not to impose copyright restrictions on your "derivative" works, but we won't try to stop you. For the legally or statist minded, you can consider yourself subject to a Creative Commons Attribution License.
India putting material into Open Access to preempt bogus patents
Through Open Access News, we learn that offense is the best defense against bogus patents. Indeed, it appears people seem to be patenting traditional Indian medicine, inducing India to incur large costs for challenging these patents. By making a database of traditional medicine available to patent offices, this should not be possible anymore as prior art is easier to establish.
[Posted at 02/13/2009 04:54 AM by Christian Zimmermann on Patents (General) 
comments(1)]
Comments
With regard to the Indian move to
protect traditional knowledge, this
movement is the culmination of many
years of attempted abuse by the big
pharma and others (like some yoga
teacher tried to patent a series of
yoga moves!).
The biggest mover on this was a guy named RA Mashelkar. His name did not appear anywhere as he was mixed up in a scandal of plagiarism. http://www.sciencemag.org/cgi/content/summary/315/5818/1475d
Tapen
[Comment at 02/28/2009 04:41 PM by Tapen Sinha]
Submit Comment
Most Recent Comments
How to extract money for using copyrighted performances The New York Times Magazine followed up on its earlier piece about The Copyright Enforcers with
at 08/29/2010 04:58 PM by John Bennett
NYTimes finds more IP news but doesn't report its consumer cost Enabling people to set up contests or awards of prizes is what I hope my Contingency Market can
at 08/28/2010 10:45 AM by Crosbie Fitch
NYTimes finds more IP news but doesn't report its consumer cost A couple of things can be done to encourage phamaceutical development without creating a monopoly.
at 08/28/2010 08:51 AM by John Bennett
Comment Posting Announcement Justin Levine's post has comments disabled again: Paul Allen Files Patent Lawsuits Against The
at 08/28/2010 03:18 AM by Crosbie Fitch
Germany Not many comments on that article. I presume that means it has a tiny audience.
Oh well, I guess
at 08/27/2010 03:22 PM by Crosbie Fitch
NYTimes finds more IP news but doesn't report its consumer cost To start with, shift the cost burden of later-stage clinical trials to the FDA and
at 08/27/2010 10:23 AM by Nobody Nowhere
NYTimes finds more IP news but doesn't report its consumer cost If I may ask a very simple question.
What would you do to encourage the "invention" of new and
at 08/27/2010 09:15 AM by MLS
Free textbooks If you are unable to get free textbooks but need cheap college books, I recommend visiting
at 08/27/2010 07:44 AM by Jay Taylor
Comment Posting Announcement Lewis Hyde's
Justin Levine has disabled
at 08/23/2010 03:25 PM by Anonymous
Music without copyright Thanks for the healthy info.
rent
at 08/23/2010 12:53 PM by Sue